These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38236166)

  • 1. Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study.
    Pleasants RA; Henderson AG; Bayer V; Shaikh A; Drummond MB
    Chronic Obstr Pulm Dis; 2024 Mar; 11(2):174-186. PubMed ID: 38236166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
    Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease.
    Pleasants RA; Shaikh A; Henderson AG; Bayer V; Drummond MB
    J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):171-179. PubMed ID: 38814000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers.
    Wu Y; Li L; Gong Y; Li X; Ye X; Zhang J
    BMC Pulm Med; 2024 Aug; 24(1):380. PubMed ID: 39095773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
    Malmberg LP; Rytilä P; Happonen P; Haahtela T
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.
    Ohar JA; Ferguson GT; Mahler DA; Drummond MB; Dhand R; Pleasants RA; Anzueto A; Halpin DMG; Price DB; Drescher GS; Hoy HM; Haughney J; Hess MW; Usmani OS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():79-92. PubMed ID: 35023914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
    Leving M; Wouters H; de la Hoz A; Bosnic-Anticevich S; Dekhuijzen R; Gardev A; Lavorini F; Meijer J; Price D; Rodríguez MR; Tsiligianni I; Usmani O; Wijnsma B; Kocks J
    Pulm Ther; 2021 Dec; 7(2):591-606. PubMed ID: 34533772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
    Mahler DA; Watz H; Emerson-Stadler R; Ritz J; Gardev A; Shaikh A; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1729-1740. PubMed ID: 37599896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
    Anderson M; Collison K; Drummond MB; Hamilton M; Jain R; Martin N; Mularski RA; Thomas M; Zhu CQ; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2021; 16():933-943. PubMed ID: 33883890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Use of Easyhaler
    Kainu A; Vartiainen VA; Mazur W; Hisinger-Mölkänen H; Lavorini F; Janson C; Andersson M
    Pulm Ther; 2024 Mar; 10(1):133-142. PubMed ID: 38170393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
    Mahler DA; Niu X; Deering KL; Dembek C
    Int J Chron Obstruct Pulmon Dis; 2022; 17():559-568. PubMed ID: 35313719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler
    Malmberg LP; Pelkonen AS; Vartiainen V; Vahteristo M; Lähelmä S; Jõgi R
    J Thorac Dis; 2021 Feb; 13(2):621-631. PubMed ID: 33717535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
    Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
    Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.